Companies Cryptocurrencies
Avidity Biosciences Inc
Avidity Biosciences Inc
Exchange: NasdaqGS
IPO Date: 12/06/2020
CEO: Ms. Sarah Boyce
Biotechnology Healthcare 🔗
  • RNA
  • 14.26
  • 709626112
    market cap
  • 0.65999985
If you bought

shares of Avidity Biosciences Inc (RNA) on
You would have made
Old Price $12 Current Price $12

Avidity Biosciences, Inc. is a biopharmaceutical company. The Company focuses on oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC), designed to overcome the limitations of oligonucleotide-based therapies to treat a range of serious diseases. It utilizes its AOC platform to design, engineer and develop therapeutics that combine the tissue selectivity of monoclonal antibodies (mAbs) and the precision of oligonucleotide-based therapies. The Oligonucleotide therapeutics are designed based on genomic information to specifically inhibit or modify the expression of disease-related proteins and ribonucleic acids (RNA). It is focused on muscle diseases and consists of approximately five programs. Its lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type one (DM1). It also focuses on other muscle programs focused on the treatment of muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy and Pompe disease.

Address: 10975 N. TORREY PINES RD. #150 La Jolla CALIFORNIA 92037

Stay updated.